Haemonetics Corp (HAE)
82.73
-0.45
(-0.54%)
USD |
NYSE |
Jun 28, 16:00
82.82
+0.09
(+0.11%)
After-Hours: 20:00
Haemonetics Net Income (Annual): 117.56M for March 31, 2024
Net Income (Annual) Chart
Historical Net Income (Annual) Data
Date | Value |
---|---|
March 31, 2024 | 117.56M |
March 31, 2023 | 115.40M |
March 31, 2022 | 43.38M |
March 31, 2021 | 79.47M |
March 31, 2020 | 76.53M |
March 31, 2019 | 55.02M |
March 31, 2018 | 45.57M |
March 31, 2017 | -26.27M |
March 31, 2016 | -55.58M |
March 31, 2015 | 16.90M |
March 31, 2014 | 35.15M |
March 31, 2013 | 38.80M |
March 31, 2012 | 66.89M |
March 31, 2011 | 79.98M |
March 31, 2010 | 58.37M |
March 31, 2009 | 59.30M |
March 31, 2008 | 51.98M |
Date | Value |
---|---|
March 31, 2007 | 49.11M |
March 31, 2006 | 69.08M |
March 31, 2005 | 39.64M |
March 31, 2004 | 29.32M |
March 31, 2003 | 28.38M |
March 31, 2002 | 30.03M |
March 31, 2001 | 7.236M |
March 31, 2000 | 15.37M |
March 31, 1999 | 21.08M |
March 31, 1998 | -24.80M |
March 31, 1997 | 32.90M |
March 31, 1996 | 35.90M |
March 31, 1995 | 33.60M |
March 31, 1994 | 31.50M |
March 31, 1993 | 24.80M |
March 31, 1992 | 18.00M |
March 31, 1991 | 13.80M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
43.38M
Minimum
2022
117.56M
Maximum
2024
86.47M
Average
79.47M
Median
2021
Net Income (Annual) Benchmarks
ResMed Inc | 897.56M |
Boston Scientific Corp | 1.593B |
Stryker Corp | 3.165B |
InfuSystems Holdings Inc | 0.872M |
Perspective Therapeutics Inc | -46.51M |